Edwards Lifesciences Corp To Host Annual Investor Conference Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Rick Wise - Stifel Nicolaus and Company, Incorporated - Analyst : Carrie, you talked about capacity constraints are real. Dr. Mack, you said -- made similar comments. I'm just curious at a simple level. You all are being very proactive in multiple ways in terms of investing in workarounds that you talked about, Dr. Mack. I'm just curious, does this sustain the kind of growth you're both talking about in your centers? Does it accelerate and meet the demand? I mean how would -- what's our takeaway from your thoughtfully aggressive initiatives here on that front?

Question: Rick Wise - Stifel Nicolaus and Company, Incorporated - Analyst : I thought I'd ask Diane a question about heart failure. She said one of the key new initiatives, I remember about a decade ago, since you acquired CardioMEMS, it seems like a good add to me then. And we've had some great data. My strong sense is that the product and technology hasn't evolved though. I'm very clear on that point. Is it enough that Cordella is new reimagined modern technology to get this market going again. Help us understand why the market is right. And I think I missed the slide on your 2030 contribution to dollars. Maybe you could tell us that number. Scott told me to ask.